AltraBio Overview

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

AltraBio General Information

Description

Operator of a contract research company intended to make gene data easily available for research. The company's services focus on the optimization of the preclinical and clinical development of candidate compounds and also provide systematic mining of public genomic and gene expression data and biomedical literature, enabling researchers to get hands-on data whenever required.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 30 rue Pré-Gaudry
  • 69007 Lyon
  • France
+33 04
Primary Industry
Media and Information Services (B2B)
Other Industries
Biotechnology
Other Healthcare Services
Vertical(s)
Corporate Office
  • 30 rue Pré-Gaudry
  • 69007 Lyon
  • France
+33 04

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AltraBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 17-Oct-2014 Completed Generating Revenue
3. Accelerator/Incubator 01-Feb-2007 Completed Startup
2. Grant 01-May-2006 Completed Startup
1. Accelerator/Incubator 01-Dec-2005 Completed Startup
To view AltraBio’s complete valuation and funding history, request access »

AltraBio Patents

AltraBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2987145-A1 Therapeutic vaccine for treating or preventing merkel cell polyoma virus-associated tumors Inactive 05-Jun-2015
EP-3101134-A1 Therapeutic vaccine for treating or preventing merkel cell polyoma virus-associated tumors Inactive 05-Jun-2015
EP-3303593-A1 Therapeutic vaccine for treating or preventing merkel cell polyoma virus-associated tumors Inactive 05-Jun-2015
US-20180201940-A1 Therapeutic vaccine for treating or preventing merkel cell polyoma virus-associated tumors Inactive 05-Jun-2015
WO-2016193389-A1 Therapeutic vaccine for treating or preventing merkel cell polyoma virus-associated tumors Inactive 05-Jun-2015 C12N15/625
To view AltraBio’s complete patent history, request access »

AltraBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AltraBio FAQs

  • Where is AltraBio headquartered?

    AltraBio is headquartered in Lyon, France.

  • What is the size of AltraBio?

    AltraBio has 6 total employees.

  • What industry is AltraBio in?

    AltraBio’s primary industry is Media and Information Services (B2B).

  • Is AltraBio a private or public company?

    AltraBio is a Private company.

  • What is AltraBio’s current revenue?

    The current revenue for AltraBio is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process